← back to search

Rishi Deka

University of California San Diego · US
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer survivorship and care, and BRCA gene mutations in cancer.
h-index
12
citations
615
works
59
NIH funding
primary concept
email

Recent publications

Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program
JNCI Journal of the National Cancer Institute 2022cited by 35position: middledoi
Incidence of stroke in the first year after diagnosis of cancer—A systematic review and meta-analysis
Frontiers in Neurology 2022cited by 25position: middledoi
BRCA testing and outcomes in women with breast cancer
Breast Cancer Research and Treatment 2021cited by 13position: middledoi
Survival of African American and non‐Hispanic white men with prostate cancer in an equal‐access health care system
Cancer 2020cited by 135position: middledoi
Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance
JAMA 2020cited by 79position: firstdoi
Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors
JNCI Journal of the National Cancer Institute 2019cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brent S. Rose · Naval Medical Center San Diego4 papers (2019–2022)James D. Murphy · UC San Diego Health System3 papers (2019–2020)Paul Riviere · University of Washington2 papers (2019–2020)Lucas K. Vitzthum · Stanford Medicine2 papers (2019–2020)Marı́a Elena Martı́nez · UC San Diego Health System2 papers (2020–2020)Elaine Luterstein · Massachusetts General Hospital2 papers (2020–2020)Vinit Nalawade · Duke University2 papers (2019–2020)Meghana S. Pagadala · University of California San Diego1 papers (2022–2022)Tori Anglin-Foote · VA Salt Lake City Healthcare System1 papers (2022–2022)Guneet K. Jasuja · Boston University1 papers (2022–2022)J. Kellogg Parsons · e-Therapeutics (United Kingdom)1 papers (2020–2020)Diana Brixner · Wilmington University1 papers (2021–2021)Andrew Bruggeman · University of California, San Diego1 papers (2020–2020)Risa Shorr · Sunnybrook Health Science Centre1 papers (2022–2022)Dar Dowlatshahi · University of Ottawa1 papers (2022–2022)Casey Tak · Primary Children's Hospital1 papers (2021–2021) · 1 papers (2022–2022)Loren K. Mell · Johns Hopkins Medicine1 papers (2019–2019)Julie A. Lynch · University of Utah1 papers (2022–2022)Richard L. Hauger · Janssen (Belgium)1 papers (2022–2022)